Translate Bio Inc (TBIO)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2021-09-14 | 2021-09-14 | S Sale |
Chief Executive Officer Executive Director |
40,909
-100.0%
38.00USD 1,554,542 |
40,909 -100.0% | 38.00 | USD 1,554,542 | |
| 2021-09-14 | 2021-09-14 | S Sale |
Chief Executive Officer Executive Director |
409,913
-100.0%
38.00USD 15,576,694 |
409,913 -100.0% | 38.00 | USD 15,576,694 | |
| 2021-09-14 | 2021-09-14 | S Sale |
Chief Executive Officer Executive Director |
503,231
-100.0%
38.00USD 19,122,778 |
503,231 -100.0% | 38.00 | USD 19,122,778 | |
| 2021-09-14 | 2021-09-14 | S Sale | Non-Executive Director |
29,860
-100.0%
38.00USD 1,134,680 |
29,860 -100.0% | 38.00 | USD 1,134,680 | |
| 2021-09-14 | 2021-09-14 | PS Planned sale | Non-Executive Director |
2,055,063
-100.0%
38.00USD 78,092,394 |
2,055,063 -100.0% | 38.00 | USD 78,092,394 | |
| 2021-09-14 | 2021-09-14 | B Purchase | Large shareholder |
20,515,985
+37.2%
38.00USD 779,607,430 |
20,515,985 +37.2% | 38.00 | USD 779,607,430 | |
| 2021-09-14 | 2021-09-14 | B Purchase | Large shareholder |
51,467,612
+1396.9%
38.00USD 1,955,769,256 |
51,467,612 +1396.9% | 38.00 | USD 1,955,769,256 | |
| 2021-09-14 | 2021-09-14 | S Sale |
Chief Operating Officer, CLO Officer |
71,833
-100.0%
38.00USD 2,729,654 |
71,833 -100.0% | 38.00 | USD 2,729,654 | |
| 2020-12-23 | 2020-12-22 | PS Planned sale | Non-Executive Director |
2,700
-5.8%
25.88USD 69,883 |
2,700 -5.8% | 25.88 | USD 69,883 | |
| 2020-12-23 | 2020-12-22 | PS Planned sale | Non-Executive Director |
79,865
-63.1%
25.04USD 1,999,987 |
79,865 -63.1% | 25.04 | USD 1,999,987 | |
| 2020-12-23 | 2020-12-21 | PS Planned sale | Non-Executive Director |
56,536
-30.9%
25.50USD 1,441,928 |
56,536 -30.9% | 25.50 | USD 1,441,928 | |
| 2020-08-27 | 2020-08-27 | S Sale | Non-Executive Director |
10,097
-0.3%
14.38USD 145,217 |
10,097 -0.3% | 14.38 | USD 145,217 | |
| 2020-08-27 | 2020-08-26 | S Sale | Non-Executive Director |
44,381
-1.1%
14.80USD 656,746 |
44,381 -1.1% | 14.80 | USD 656,746 | |
| 2020-08-27 | 2020-08-25 | S Sale | Non-Executive Director |
34,410
-0.9%
15.00USD 516,160 |
34,410 -0.9% | 15.00 | USD 516,160 | |
| 2020-06-05 | 2020-06-03 | S Sale |
Shire Human Genetic Therapies, Inc. Large shareholder |
40,086
-0.6%
19.75USD 791,699 |
40,086 -0.6% | 19.75 | USD 791,699 | |
| 2020-06-03 | 2020-06-02 | S Sale |
Shire Human Genetic Therapies, Inc. Large shareholder |
5,006
-0.1%
20.02USD 100,220 |
5,006 -0.1% | 20.02 | USD 100,220 | |
| 2020-06-03 | 2020-06-02 | S Sale |
Shire Human Genetic Therapies, Inc. Large shareholder |
100,389
-1.4%
19.75USD 1,982,683 |
100,389 -1.4% | 19.75 | USD 1,982,683 | |
| 2020-06-03 | 2020-06-01 | S Sale |
Shire Human Genetic Therapies, Inc. Large shareholder |
1,400
-0.0%
20.53USD 28,742 |
1,400 -0.0% | 20.53 | USD 28,742 | |
| 2020-06-03 | 2020-06-01 | S Sale |
Shire Human Genetic Therapies, Inc. Large shareholder |
107,072
-1.5%
19.85USD 2,125,379 |
107,072 -1.5% | 19.85 | USD 2,125,379 | |
| 2018-07-05 | 2018-07-02 | B Purchase |
Gallagher Brian M. Jr. Non-Executive Director |
269,230
+7.9%
13.00USD 3,499,990 |
269,230 +7.9% | 13.00 | USD 3,499,990 | |
| 2018-07-03 | 2018-07-02 | B Purchase |
MRL Ventures Fund LLC Large shareholder |
25,000
+1.4%
13.00USD 325,000 |
25,000 +1.4% | 13.00 | USD 325,000 | |
| 2018-07-03 | 2018-07-02 | B Purchase |
GLAXOSMITHKLINE PLC Large shareholder |
269,230
+7.9%
13.00USD 3,499,990 |
269,230 +7.9% | 13.00 | USD 3,499,990 |